SMS Reminders and Treatment Compliance and Efficacy in Patients With FGIDs
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04052750|
Recruitment Status : Recruiting
First Posted : August 12, 2019
Last Update Posted : August 12, 2019
|Condition or disease||Intervention/treatment||Phase|
|Functional Gastrointestinal Disorders Patient Compliance||Behavioral: SMS follow-up||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||176 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Outcomes Assessor)|
|Official Title:||Daily Short Message Service Reminders Increase Treatment Compliance and Efficacy in Outpatients With Functional Gastrointestinal Disorders: a Randomized Controlled Trial|
|Actual Study Start Date :||April 30, 2019|
|Estimated Primary Completion Date :||April 30, 2020|
|Estimated Study Completion Date :||April 30, 2021|
No Intervention: The control group
Patients in this group only received medications without daily text message reminder
Experimental: The intervention group
Patients in this group received a daily short message service (SMS) reminder when medications were prescribed
Behavioral: SMS follow-up
In addition to conventional treatment, the experimental group received SMS reminding every day until the end of the treatment.
- Treatment compliance in outpatients with FGIDs [ Time Frame: week2 ]Compliance is assessed by the medication possession ratio (MPR). The MPR is often defined as the sum of the days' supply of medication divided by the number of days between the first fill and the last refill plus the days' supply of the last refill. This calculation usually results in a ratio less than 1.0 if there are lapses in prescription refilling.
- Improvement of abdominal pain in outpatients with FGIDs [ Time Frame: week2 ]Improvement of abdominal pain symptom was assessed by comparison of symptom score after treatment to that before treatment. The pain symptome was assessed by Visual Analog Score for pain with the following creteria: 0, no pain; 1, mild; 2, related; 3, severe; 4, very severe. Higher values represent a worse outcome.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04052750
|Contact: Shengliang Chen 86-21-58752345 email@example.com|